Business

USFDA inspection at Indore facility ends with zero observations: Cipla

USFDA inspection at Indore facility ends with zero observations: Cipla #39;We would like to inform you that the USFDA (US Food and Drug Administration) conducted a post-approval inspection at our Indore facility from 13th May to 17th May, 2019. The inspection ended with zero observations,#39; the company said in a BSE filing.

from Moneycontrol Business News
Read The Rest:moneycontrol...

Realted Posts